T1	Participants 81 144	95 patients with anterior tongue and floor of the mouth cancers
T4	Participants 247 306	one-third of the patients received chemotherapy for 2 years
T5	Participants 417 513	one-third of the patients received immunotherapy with weekly C. parvum injections during 2 years
T6	Participants 525 570	remaining third did not receive any treatment
